4th Quarter - Report
BIOCOM for BIOCOM
Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Advocated for increased funding for NIH and FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Taxation/Internal Revenue Code TAX
Advocated for repeal of the medical device tax. Advocated for lower corporate tax rate and territorial tax system as part of tax reform. Advocated for protection of the orphan drug tax credit and state and local tax deductions, as part of tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Advocated for the repeal of IPAB
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.